ALPMF News and Press, Astellas Pharma Inc From 09/27/18

Conducting biopharmaceutical research initiated by Merck ( MRK ) and with a massive market opportunity, Urovant ( UROV ) seems an interesting name to be followed once the IPO goes live. With that, the facts that the company was incorporated in Cayman and Roivant Sciences Ltd. controls the comp...

The following slide deck was published by Astellas Pharma, Inc. ADR in conjunction with their 2018 Q2 earnings Read more ...

The FDA accepts under Priority Review  Astellas Pharma's ( OTCPK:ALPMF )( OTCPK:ALPMY ) marketing application seeking approval for gilteritinib for the treatment of adult patients with relapsed/refractory FLT3-positive acute myeloid leukemia (AML). The agency's action date is November ...

The following slide deck was published by Astellas Pharma, Inc. ADR in conjunction with this Read more ...

Read more ...

Pfizer (NYSE: PFE ) and collaboration partner Astellas Pharma ( OTCPK:ALPMF ) announce that the FDA has accepted under Priority Review the former's marketing application seeking approval for XTANDI (enzalutamide) for the treatment of men with non-metastatic castration-resistant prostate ca...

Noteworthy events for the week of Feb. 4 - 10 for healthcare investors: More news on: Protalix BioTherapeutics, Inc, Bristol-Myers Squibb Company, WellCare Health Plans, Inc., Healthcare stocks news, Read more ...

Astellas Pharma ( OTCPK:ALPMF ): 9M net profit of  ¥ 167.88B. More news on: Astellas Pharma, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Note: Subscribers to Avisol Capital Partners' Total Pharma Tracker got an early look at this publication. Consider becoming a subscriber today to get early access! Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep p...

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec...